Product Images Simulect
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Simulect NDC 0078-0331 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
simulect 01
This appears to be a graph showing the Kaplan-Meier estimate of the percentage of subjects who experience death, graft loss, or their first rejection episode within the first year (0-12 months) after undergoing dual therapy. The x-axis may represent different time points, with 6 months being the first data point shown. The y-axis appears to show the percentage of subjects experiencing the defined events. The graph shows that at 6 months, approximately 50% of subjects have experienced one of the defined events.*
Figure 1: Kaplan-Meier Estimate of the Percentage of Subjects with Death, Graft Loss or First Rejection Episode (Dual Therapy) - simulect 02
This appears to be a packaging label for the drug "Simulect" by the pharmaceutical company Novartis. The label shows the dosage information for a 10mg single-dose vial of the drug for injection.*
simulect 03
Simulect is a medication produced by Novartis and is available in single dose vials of 20mg for injection. No other information is available due to the poor quality of the text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.